Leerink Partners analyst Marc Goodman reiterated a Buy rating on Avadel Pharmaceuticals (AVDL – Research Report) on November 12 and set a ...

Discover the top sales and marketing intelligence solutions tailored for the pharmaceutical industry. Download our guide to predictive analytics and data-driven insights.

Graig Suvannavejh’s rating is based on several compelling aspects of Corvus Pharmaceuticals’ recent developments ... The potential market opportunity is vast, with projected sales reaching $2.5 ...

By leveling up their streaming campaigns, advertisers can achieve big lifts in awareness and sales of their medications among ...

POTOMAC, MD / ACCESSWIRE / November 14, 2024 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American ... Innovative ...

On Wednesday, Zentalis Pharmaceuticals Inc (ZNTL) stock saw a modest uptick, ending the day at $3.92 which represents a slight increase of $0.21 or 5.66% from the prior close of $3.71. The stock ...

Despite a net loss, ARS Pharmaceuticals Inc (SPRY) is optimistic about NEPHI's market potential and strategic global expansion.

GSK’s 3 billion pounds sterling peak sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks ...

On Tuesday, Recursion Pharmaceuticals Inc (RXRX) stock saw a decline, ending the day at $7.58 which represents a decrease of $-0.26 or -3.32% from the prior close of $7.84. The stock opened at $7.52 ...

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

The German pharma and ... predicted 2024 sales between 20.7 billion and 22.1 billion euros, said it was now guiding for the ...

Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.